Optimization of Pulsatile Compression Coated Floated tablets of Tramadol HCL for Chronopharmacotherapy of Rheumatoid Arthritic pain using 23 Factorial Design

Pasam Jyothirmayi; G. Devalarao; Mandava Venkata Basaveswara Rao

doi:10.5958/0974-360X.2020.01015.X

Research Journal of Pharmacy and Technology

ISSN

0974-360X (Online)
0974-3618 (Print)

Submit Article

Optimization of Pulsatile Compression Coated Floated tablets of Tramadol HCL for Chronopharmacotherapy of Rheumatoid Arthritic pain using 23 Factorial Design

Author(s): Pasam Jyothirmayi, G. Devalarao, Mandava Venkata Basaveswara Rao

Email(s): jyothipasam@gmail.com

DOI: 10.5958/0974-360X.2020.01015.X

Address: Pasam Jyothirmayi1*, Dr. G. Devalarao2, Mandava Venkata Basaveswara Rao3
1Research Scholar, Krishna University, Krishna District, Andhra Pradesh, India. 2Department of Pharmaceutical Analysis, K.V. S. R Siddhartha College of Pharmaceutical Sciences, Vijayawada, Andhra Pradesh, India.
3Department of Chemistry, Krishna University, Krishna District, Andhra Pradesh, India.
*Corresponding Author

Published In: Volume - 13, Issue - 12, Year - 2020

View HTML

Purchase PDF

ABSTRACT:
Objective: The main aim of study is to develop modified oral compression coated floated tablets for pulsatile delayed release of Tramadol HCL by applying design of experiments (DOE). Pulsatile release systems are generally formulated to undergo a lag-time of predetermined span of time of no release, followed by a rapid and complete release of loaded drugs. Methods: These systems consist of three steps in formulation. In the first step burst release core tablets of Tramadol HCL were prepared with superdisintegrants such as Cross Povidone, Sodium Starch Glycolate and Cross Carmellose Sodium. In second step, these core tablets were compression coated with polymers HPMC K4M, HPMC K15M, Ispaghula gum and Tamarindus gum to assign suitable lag time to formulation. In third step, top buoyant layer was compressed using suitable polymers such as HPMC K100M, Ispaghula gum and their combination. Results: In the preliminary two steps, immediate release core tablets were optimized with formulation CF2 which contains sodium starch Glycolate 8% as immediate release agent. Then in compression coated formulation CCF8 was optimized. Among complete coated floated formulation BF4 and BF8 shows significant lag time of 5hr and drug release for a period of 12 hrs. Conclusion: A modified oral compression coated floated tablets for pulsatile delayed release of Tramadol HCL was made possible with BF4 and BF8 which shows better drug release with suitable lag time and drug release and fulfilled my objective of work.

Keywords:

Cite this article:
Pasam Jyothirmayi, G. Devalarao, Mandava Venkata Basaveswara Rao. Optimization of Pulsatile Compression Coated Floated tablets of Tramadol HCL for Chronopharmacotherapy of Rheumatoid Arthritic pain using 23 Factorial Design. Research J. Pharm. and Tech. 2020; 13(12):5823-5830. doi: 10.5958/0974-360X.2020.01015.X

REFERENCES:
1.   American College of Rheumatology. Ad Hoc Committee on Clinical Guidelines. Guidelines for the management of rheumatoid arthritis. Arthritis Rheum 1996;39: 713–22.
2.   Bellamy N, Sothern RB, Campbell J, Buchanan WW. Circadian rhythm in pain, stiffness, and manual dexterity in rheumatoid arthritis: relation between discomfort and disability. Ann Rheum Dis. 1991;50(4): 243–248.
3.   Kowanko IC, Knapp MS, Pownall R, Swannell AJ. Domiciliary self-measurement in the rheumatoid arthritis and the demonstration of circadian rhythmicity. Ann Rheum Dis. 1982;41(5):453–455.
4.   Chopra D, Gulati M, Singh S, Duggal S, Kumar R. Use of liposomal drugs in the treatment of rheumatoid arthritis. Curr Rheumatol Rev 2008;4: 63-70.
5.   Ghosh R, Alajbegovic A, Gomes AV. NSAIDs and cardiovascular diseases: Role of reactive oxygen species. Oxid Med Cell Longev 2015;2015: 53-69.
6.   Data sheet of Tramadol. http://www.medsafe.govt.nz/profs/ Datasheet/ Grunenthal GmbH. 2012, 1-14.
7.   Mandal AS, Biswas N, Karim KM, Guha A, Chatterjee S, Behera M. Drug delivery system based on chronobiology - A review. J Control Release 2010;147:314-25.
8.   B. Lemmer, “Circadian rhythms and drug delivery,” Journal of Controlled Release, vol. 16, no. 1-2, pp. 63–74, 1991.
9.   H. D. Savani, J. Turakhiya, J. Patel, M. Goyani, and B. Akbari, “Floating pulsatile drug delivery system: a review,” Universal Journal of Pharmacy, vol. 2, no. 1, pp. 6–13, 2013.
10.   S.-Y. Lin and Y. Kawashima, “Current status and approaches to developing press-coated chrono delivery drug systems,” Journal of Controlled Release, vol. 157, no. 3, pp. 331–353, 2012.
11.   Conte U, Maggi L, Torre ML, Giunchedi P, La Manna A. Press-coated tablets for time-programmed release of drugs. Biomaterials 1993;14:1017-23.
12.   Sinha VR, Singh A, Singh S, Bhinge JR. Compression coated systems for colonic delivery of 5-fluorouracil. J Pharm Pharmacol 2007; 59:359-65.
13.   Giriraj KT, Gowthamarajan K, Brahmaji G and Suresh B. J Scientific Ind Res 2002; 61: 529-532.
14.   Malviya R, Srivastava P, Bansal M, Sharma PK. Formulation, Evaluation and Comparison of Sustained Release Matrix Tablets of Diclofenac Sodium Using tamarind Gum as Release Modifier. Asian J Pharma Clin Res. 2010; 3(3):238-41.
15.   S. C. Jagdale, N. A. Bari, B. S. Kuchekar, and A. R. Chabukswar, “Optimization studies on compression coated floating-pulsatile drug delivery of bisoprolol,” BioMed Research International, vol.1,2013, Article ID801769, 11 pages, 2013.
16.   Vishnumurthy vummaneni et al. Formulation and optimization of famotidine floating tablets using 23 factorial design/ journal of pharmacy research 2012,5(12):5280-528.
17.   Reddy KJ, Mohan GK, Gaikwad BS Preliminary phytochemical standardization of tree exudates from India: Gum kondagogu and Gum ghatti. RJPBCS, 2011; 2: 1023-1033.
18.   Ashok GV, Priya BS, Pranita GA Evaluation of Antibacterial and phytochemical analysis of Mangifera Bark Extract. Int .j.curr. Microbiol. App sci, 2014; 3: 567-580.
19.   M. E. Aulton, Aulton’s Pharmaceutics: The Design and Manufacture of Medicine, vol. 133, Elsevier Churchill Livingstone, 2ndedition, 2008.
20.   Government of India, “Ministry of health and welfare,” in Indian Pharmacopoeia, vol. 587, pp. 187–193,Controller of Publications, New Delhi, India, 2010.
21.   S. Jagdale, M. Sali, A. Barhate, J. Loharkar, B. Kuchekar, and A. Chabukswar, “Development of pulsatile release tablets of atenolol with swelling and rupturable layers,” International Journal of Applied Pharmaceutics, vol. 2, no. 3, pp. 31–40, 2010.
22.   S. C. Jagdale, S. A. Patil, and B. S. Kuchekar, “Design, development and evaluation of floating tablets of tapentadol hydrochloride using Chitosan,” AJPCR: Asian Journal of Pharmaceutical and Clinical Research, vol. 5, no. 4, pp. 163–168, 2012.
23.   L.V. Allen,N. G. Popovich, and H. C. Ansel, Ansel’s Pharmaceutical Dosage Form and Drug Delivery System, Lippincott William and Wilkins, Philadelphia, Pa, USA, 9th edition, 2008.

Recomonded Articles:

Formulation and Evaluation of Diclofenac gel

Author(s): Priya P. Munshi, D.S. Mohale, R. Akkalwar, A.V. Chandewar

DOI: Not Available Access: Open Access Read More

Formulation Development and Characterization of Etodolac Loaded Transethosomes for Transdermal Delivery

Author(s): S. B. Gondkar, Neha R. Patil, R. B. Saudagar

DOI: 10.5958/0974-360X.2017.00541.8 Access: Open Access Read More

Formulation and Evaluation of Mouth Dissolving Tablets of Domperidone

Author(s): Avinash Bhagwat, Suhas M Kakade, Chirag V Naval, Mukesh Tilker, Ravindra M Walture, Sagar A Adichwal and Atul P Chaudhari

DOI: Not Available Access: Open Access Read More

Formulation and Evaluation of Sustained Release Floating Matrix Tablets of Labetalol Hydrochloride.

Author(s): Ravi K. Barde, Minal R. Narkhede, V.R. Gudsoorkar, Rahul K. Amrutkar, Prashant S. Walke

DOI: Not Available Access: Open Access Read More

Formulation and in vitro evaluation of gastroretentive drug delivery systems of amoxicillin trihydrate

Author(s): Mohammed Ehtesham Ur Rahman, Mohammed Abdul Haseeb, Mohammed Saleem, Abdul Naveed

DOI: Not Available Access: Open Access Read More

Formulation and Evaluation of Fast Dissolving Tablet of Telmisartan

Author(s): Priti Patel, Ashok Kumar P., Hemil Shah, Nikunj Patel, Pratik Kheni, Someshwara Rao B., Suresh V. Kulkarni, Babitha S.

DOI: Not Available Access: Open Access Read More

Formulation and Evaluation of Mouth Dissolving Tablets of Clozapine by Direct Compression Method

Author(s): N. Sravanthi, Alekhya, I. Vikram Reddy

DOI: 10.5958/0974-360X.2017.00450.4 Access: Open Access Read More

Formulation and Evaluation of Dispersible Tablets of Sudarshan, Vyswanara and Panchasakar Churnas

Author(s): Mettu Srikanth Reddy, Mallikarjun Setty

DOI: Not Available Access: Open Access Read More

Formulation and evaluation of orodispersible tablet of montelukast sodium

Author(s): Siddharth Kumar Sahu, Ajazuddin, Tripti Banjare, Swapnil Gupta, Akansha Bhandarkar, Hemlata Sahu, Shradha Devi Diwedi, Pankaj Sahu, Palak Agrawal, Pooja Yadav, Aditi Bhatt, Kailash Sahu, Deeksha Dewangan, HemlataThapa, Deepika, GyaneshSahu, Mukesh Sharma, D. K. Tripathi, Amit Alexander

DOI: 10.5958/0974-360X.2018.00209.3 Access: Open Access Read More